Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 34 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

12%

4 trials in Phase 3/4

Results Transparency

18%

3 of 17 completed trials have results

Key Signals

5 recruiting3 with results

Enrollment Performance

Analytics

N/A

10(40.0%)

Phase 1

6(24.0%)

Phase 2

5(20.0%)

Phase 3

2(8.0%)

Phase 4

2(8.0%)

25Total

N/A(10)

Phase 1(6)

Phase 2(5)

Phase 3(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (34)

Showing 20 of 34 trials

NCT07019610Not ApplicableNot Yet Recruiting

Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial

Role: collaborator

NCT06510699Phase 2Recruiting

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

Role: collaborator

NCT06476639Phase 3Not Yet Recruiting

A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer

Role: collaborator

NCT06264167Not ApplicableRecruiting

NODE (groiN ultrasOunD cancEr)

Role: collaborator

NCT04986254Completed

PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)

Role: collaborator

NCT03487263Phase 1Completed

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

Role: collaborator

NCT07101055Phase 1Not Yet Recruiting

Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis

Role: collaborator

NCT04157595Not ApplicableCompleted

Mackenzie's Mission: The Australian Reproductive Carrier Screening Project

Role: collaborator

NCT04643327Phase 2Recruiting

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease

Role: collaborator

NCT06157541Phase 1Recruiting

T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma

Role: collaborator

NCT06148051Recruiting

AusCADASIL: An Australian Cohort of CADASIL

Role: collaborator

NCT05400616Not ApplicableUnknown

Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Role: collaborator

NCT05182931Phase 2Unknown

A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)

Role: collaborator

NCT05741866Not ApplicableUnknown

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)

Role: collaborator

NCT05256316Completed

Risks of Bacterial and Fungal Superinfection in Patients With COVID-19

Role: collaborator

NCT04943731Not ApplicableCompleted

Day/Night Regimen With Provox Life Heat and Moisture Exchangers

Role: collaborator

NCT02258165Completed

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer

Role: collaborator

NCT02226302Completed

Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer

Role: collaborator

NCT03309657Phase 1Completed

Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid

Role: lead

NCT02962934Completed

An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT

Role: lead